Skip to main content
Premium Trial:

Request an Annual Quote

Helicos Expands License for Arizona State University Patents to Include Non-Optical Detection Methods

Premium

Helicos BioSciences has expanded its existing license with Arizona Technology Enterprises, the tech transfer organization for Arizona State University, to include detection methods that do not rely on optically labeled nucleotides, the company said today.

"The newly acquired rights will be an important asset in our licensing and IP monetization efforts," said Ivan Trifunovich, Helicos' president and CEO, in a statement.

"As we witness the rapid expansion of next-generation sequencing applications covered by our patents in the research and molecular diagnostic fields, we intend to maximize the return to our stakeholders through a licensing program and IP enforcement mechanisms."

Helicos is currently suing Pacific Biosciences, Illumina, and Life Technologies for alleged infringement of its patents (IS 7/26/2011).

The company also said that eight new patents issued or were allowed, and that it has filed more than a dozen patent applications this year.

Two new patents, US Patent Nos. 7,875,440 and 7,897,345, "contain very broad claims that cover the very core chemistry of most major next-generation sequencing platforms," the company said.

The '440 patent is currently the subject of an inter partes reexamination by the US Patent and Trademark Office that was requested by Life Technologies and granted by the USPTO on Aug. 17.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.